<?xml version="1.0" encoding="utf-8"?> 
<rss version="2.0"
  xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd"
  xmlns:atom="http://www.w3.org/2005/Atom">

<channel>

<title>Konstantin Chernyshov: posts tagged 2024</title>
<link>https://kostachernyshov.com/blog/tags/2024/</link>
<description>Konstantin Chernyshov, manager, bioinformatic, leader in biotech</description>
<author></author>
<language>en</language>
<generator>Aegea 11.4 (v4171e)</generator>

<itunes:subtitle>Konstantin Chernyshov, manager, bioinformatic, leader in biotech</itunes:subtitle>
<itunes:image href="https://kostachernyshov.com/blog/pictures/userpic/userpic-square@2x.jpg?1731242071" />
<itunes:explicit>no</itunes:explicit>

<item>
<title>Publications in 2024</title>
<guid isPermaLink="false">34</guid>
<link>https://kostachernyshov.com/blog/all/publications-in-2024/</link>
<pubDate>Sun, 03 May 2026 18:19:29 +0400</pubDate>
<author></author>
<comments>https://kostachernyshov.com/blog/all/publications-in-2024/</comments>
<description>
&lt;p&gt;In 2024, I worked as the head of a group of bioinformaticians at BostonGene. Part of our department’s work involves scientific research on topical subjects that we either generate ourselves or receive as a client request. Participating in conferences allows us to present ourselves as experts in the field, make new acquaintances, and start projects.&lt;/p&gt;
&lt;p&gt;As a project lead, I proposed research topics, kept track of deadlines and workloads. Below are selected projects.&lt;/p&gt;
&lt;h2&gt;American Society of Clinical Oncology&lt;/h2&gt;
&lt;p&gt;The main clinical oncology conference in the USA.&lt;/p&gt;
&lt;div class="e2-text-picture"&gt;
&lt;div class="fotorama" data-width="1605" data-ratio="1.716577540107"&gt;
&lt;img src="https://kostachernyshov.com/blog/pictures/fusions-in-osteo.png" width="1605" height="935" alt="" /&gt;
&lt;img src="https://kostachernyshov.com/blog/pictures/fusions-in-osteo-zoom1.png" width="962" height="841" alt="" /&gt;
&lt;img src="https://kostachernyshov.com/blog/pictures/fusions-in-osteo-zoom2.png" width="1066" height="788" alt="" /&gt;
&lt;/div&gt;
&lt;div class="e2-text-caption"&gt;“Transcriptomic Analysis Identifies Novel Tumor Suppressor Gene Fusions in Bone Sarcomas”.&lt;br /&gt;
&lt;a href="https://doi.org/10.1200/JCO.2024.42.16_suppl.11523"&gt;ASCO abstracts&lt;/a&gt;.&lt;/div&gt;
&lt;/div&gt;
&lt;h2&gt;Society of Immunotherapy of Cancer&lt;/h2&gt;
&lt;p&gt;The largest conference on cancer immunotherapy; this year it took place in Barcelona.&lt;/p&gt;
&lt;div class="e2-text-picture"&gt;
&lt;div class="fotorama" data-width="1595" data-ratio="1.6842661034847"&gt;
&lt;img src="https://kostachernyshov.com/blog/pictures/adc-in-sarc.png" width="1595" height="947" alt="" /&gt;
&lt;img src="https://kostachernyshov.com/blog/pictures/adc-in-sarc-zoom1.png" width="1159" height="787" alt="" /&gt;
&lt;img src="https://kostachernyshov.com/blog/pictures/adc-in-sarc-zoom2.png" width="1025" height="942" alt="" /&gt;
&lt;/div&gt;
&lt;div class="e2-text-caption"&gt;“Identifying novel targets for antibody-drug conjugates in sarcomas using RNA sequencing”.&lt;br /&gt;
&lt;a href="https://bostongene.com/news-and-publications/publications/identifying-novel-targets-for-antibody-drug-conjugates-in-sarcomas-using-rna-sequencing?qr=1"&gt;BostonGene news&lt;/a&gt;.&lt;br /&gt;
&lt;a href="https://doi.org/10.1136/jitc-2024-SITC2024.0170"&gt;SITC abstracts&lt;/a&gt;.&lt;/div&gt;
&lt;/div&gt;
&lt;h2&gt;Association of Molecular Pathology&lt;/h2&gt;
&lt;p&gt;A large conference in Canada attended by pathologists, pharma and biotech.&lt;/p&gt;
&lt;div class="e2-text-picture"&gt;
&lt;div class="fotorama" data-width="1599" data-ratio="1.7746947835738"&gt;
&lt;img src="https://kostachernyshov.com/blog/pictures/CCS-full.png" width="1599" height="901" alt="" /&gt;
&lt;img src="https://kostachernyshov.com/blog/pictures/CCS-zoom1.png" width="1579" height="886" alt="" /&gt;
&lt;/div&gt;
&lt;div class="e2-text-caption"&gt;“Comparative Molecular Analysis of Clear Cell Sarcoma and Cutaneous Melanomas: Key Genetic Insights for diagnosis”. &lt;a href="https://bostongene.com/news-and-publications/publications/comparative-molecular-analysis-of-clear-cell-sarcoma-and-cutaneous-melanomas-key-genetic-insights-for-diagnosis?qr=1"&gt;BostonGene news&lt;/a&gt;.&lt;br /&gt;
&lt;a href="https://doi.org/10.1016/S1525-1578(24)00232-0"&gt;APM abstracts&lt;/a&gt;.&lt;/div&gt;
&lt;/div&gt;
&lt;h2&gt;American Society of Hematology&lt;/h2&gt;
&lt;p&gt;The largest conference on lymphomas and blood disorders in the world.&lt;/p&gt;
&lt;div class="e2-text-picture"&gt;
&lt;img src="https://kostachernyshov.com/blog/pictures/dlbcl-full.png" width="1486" height="954" alt="" /&gt;
&lt;div class="e2-text-caption"&gt;“Gene Expression-Based Classifier Reclassifies Burkitt Lymphoma, HGBL NOS, DLBCL NOS, and Double/Triple Hit Lymphomas into Subtypes with More Mutational and Microenvironment Landscapes and Treatment Response”. &lt;a href="https://bostongene.com/news-and-publications/publications/gene-expression-based-classifier-reclassifies-burkitt-lymphoma-hgbl-nos-dlbcl-nos-and-double-triple-hit-lymphomas-into-subtypes-with-more-uniform-mutational-and-microenvironment-landscapes-and-treatment-response?qr=1"&gt;BostonGene news&lt;/a&gt;.&lt;br /&gt;
&lt;a href="https://ash.confex.com/ash/2024/webprogram/Paper200975.html"&gt;ASH conference website&lt;/a&gt;.&lt;/div&gt;
&lt;/div&gt;
&lt;h2&gt;San-Antonio Breast Cancer Symposium&lt;/h2&gt;
&lt;p&gt;The largest breast cancer conference in the world.&lt;/p&gt;
&lt;div class="e2-text-picture"&gt;
&lt;div class="fotorama" data-width="1599" data-ratio="1.7323943661972"&gt;
&lt;img src="https://kostachernyshov.com/blog/pictures/adc-in-ilc.png" width="1599" height="923" alt="" /&gt;
&lt;img src="https://kostachernyshov.com/blog/pictures/adc-in-ilc-zoom1.png" width="1097" height="903" alt="" /&gt;
&lt;/div&gt;
&lt;div class="e2-text-caption"&gt;“Comprehensive Analysis of ADC Target Expression in Invasive Lobular Carcinoma”.&lt;br /&gt;
&lt;a href="https://bostongene.com/news-and-publications/publications/comprehensive-analysis-of-adc-target-expression-in-invasive-lobular-carcinoma?qr=1"&gt;BostonGene news&lt;/a&gt;.&lt;/div&gt;
&lt;/div&gt;
&lt;div class="e2-text-picture"&gt;
&lt;div class="fotorama" data-width="1593" data-ratio="1.7428884026258"&gt;
&lt;img src="https://kostachernyshov.com/blog/pictures/FISH-vs-NGS-full.png" width="1593" height="914" alt="" /&gt;
&lt;img src="https://kostachernyshov.com/blog/pictures/FISH-vs-NGS-zoom-1.png" width="1544" height="871" alt="" /&gt;
&lt;img src="https://kostachernyshov.com/blog/pictures/FISH-vs-NGS-zoom-2.png" width="920" height="907" alt="" /&gt;
&lt;/div&gt;
&lt;div class="e2-text-caption"&gt;“Evaluating the Correlation Between FISH and NGS in Assessing ERBB2 Amplification in Breast Cancer: Insights and Implications”. &lt;a href="https://bostongene.com/news-and-publications/publications/evaluating-the-correlation-between-fish-and-ngs-in-assessing-erbb2-amplification-in-breast-cancer-insights-and-implications?qr=1"&gt;BostonGene news&lt;/a&gt;.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>


</channel>
</rss>